Susquehanna International Group, LLP Gritstone Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.45 - $0.71 $1,530 - $2,414	3,400 Added 4.93%	72,300 $41,000
Q2 2024 Aug 15, 2024	SELL	$0.62 - $2.35 $183,086 - $693,955	-295,300 Reduced 81.08%	68,900 $42,000
Q1 2024 May 07, 2024	BUY	$1.96 - $2.9 $608,972 - $901,030	310,700 Added 580.75%	364,200 $935,000
Q4 2023 Feb 14, 2024	BUY	$1.28 - $2.85 $10,496 - $23,370	8,200 Added 18.1%	53,500 $109,000
Q3 2023 Nov 14, 2023	BUY	$1.19 - $2.26 $32,606 - $61,923	27,400 Added 153.07%	45,300 $77,000
Q2 2023 Aug 11, 2023	SELL	$1.66 - $3.03 $37,350 - $68,175	-22,500 Reduced 55.69%	17,900 $34,000
Q1 2023 May 16, 2023	BUY	$2.13 - $3.74 $32,589 - $57,222	15,300 Added 60.96%	40,400 $112,000
Q4 2022 Feb 14, 2023	SELL	$2.17 - $3.92 $68,138 - $123,088	-31,400 Reduced 55.58%	25,100 $86,000
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $3,444 - $6,650	1,400 Added 2.54%	56,500 $145,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.